ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
William Norwood
Demetre M. Nicoloff
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dunn, D.
Right arrow Articles by Nicoloff, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dunn, D.
Right arrow Articles by Nicoloff, D. M.

Ann Thorac Surg 1978;26:241-249
© 1978 The Society of Thoracic Surgeons


Articles

Bronchioloalveolar Cell Carcinoma of the Lung: A Clinicopathological Study

Daniel Dunn, M.D., Bruce Hertel, M.D., William Norwood, M.D., Demetre M. Nicoloff, M.D.*

Departments of Surgery and Pathology, University of Minnesota Hospitals, Minneapolis, MN, and the Division of Cardiac Surgery, Boston Children's Hospital, Boston, MA

* Address reprint requests to Dr. Nicoloff, Box 280 Mayo-University Hospitals, 420 Delaware St, SE, Minneapolis, MN 55455

Thirty-nine patients with bronchioloalveolar carcinoma were reviewed. The primary lung tumor from 27 patients was examined and divided by histological criteria into three categories. The type 1 pattern was associated with a mean survival of 4.7 years. A mean survival of 3.8 years was attained in patients with type 2. Patients with the type 3 pattern had an average survival of 1.4 years. There was a statistically significant difference in survival when types 1 and 2 together were compared with type 3 (p < 0.05). Another statistically significant finding was a mean survival of 5.2 years in patients with negative lymph nodes after surgical resection and a 2.2 year mean survival in patients with positive nodes. The tumor histology of bronchioloalveolar carcinoma should be examined carefully to obtain helpful information in predicting survival. We recommend that these tumors be classified as well-differentiated or poorly differentiated bronchioloalveolar carcinoma.




This article has been cited by other articles:


Home page
Eur J Cardiothorac SurgHome page
F. Barlesi, C. Doddoli, C. Gimenez, B. Chetaille, R. Giudicelli, P. Fuentes, J.-P. Kleisbauer, and P. Thomas
Bronchioloalveolar carcinoma: myths and realities in the surgical management
Eur J Cardiothorac Surg, July 1, 2003; 24(1): 159 - 164.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
O. S. Breathnach, D. J. Kwiatkowski, D. M. Finkelstein, J. Godleski, D. J. Sugarbaker, B. E. Johnson, and S. Mentzer
Bronchioloalveolar carcinoma of the lung: Recurrences and survival in patients with stage I disease
J. Thorac. Cardiovasc. Surg., January 1, 2001; 121(1): 0042 - 47.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. C. Holmes
Carcinoma of the Lung
Ann. Thorac. Surg., May 1, 1988; 45(5): 582 - 582.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1978 by The Society of Thoracic Surgeons.